🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors market the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.

Some professionals stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

Based on the social media company, the service has taken down problematic material and prohibited associated keywords and query recommendations. The organization said it was committed to keeping the platform secure and investing in strengthening compliance measures.

Online Marketplace Operations

Research also found communities with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home.

Within minutes of entering one community, a vendor posted contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, health issues or past usage.

Product Information and Costs

Within these groups, posts show black plastic parcels with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When questioned how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service stated it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly significant medical dangers”.